These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25103720)

  • 1. OX40 and IL-7 play synergistic roles in the homeostatic proliferation of effector memory CD4⁺ T cells.
    Yamaki S; Ine S; Kawabe T; Okuyama Y; Suzuki N; Soroosh P; Mousavi SF; Nagashima H; Sun SL; So T; Sasaki T; Harigae H; Sugamura K; Kudo H; Wada M; Nio M; Ishii N
    Eur J Immunol; 2014 Oct; 44(10):3015-25. PubMed ID: 25103720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homeostatic proliferation of naive CD4+ T cells in mesenteric lymph nodes generates gut-tropic Th17 cells.
    Kawabe T; Sun SL; Fujita T; Yamaki S; Asao A; Takahashi T; So T; Ishii N
    J Immunol; 2013 Jun; 190(11):5788-98. PubMed ID: 23610141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
    Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice.
    Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M
    Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
    Ruby CE; Redmond WL; Haley D; Weinberg AD
    Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood monocytes, myeloid dendritic cells and the cytokines interleukin (IL)-7 and IL-15 maintain human CD4+ T memory cells with mixed helper/regulatory function.
    McKinlay A; Radford K; Kato M; Field K; Gardiner D; Khalil D; Burnell F; Hart D; Vuckovic S
    Immunology; 2007 Mar; 120(3):392-403. PubMed ID: 17239200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo.
    Xiao X; Kroemer A; Gao W; Ishii N; Demirci G; Li XC
    J Immunol; 2008 Sep; 181(5):3193-201. PubMed ID: 18713990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential requirements for OX40 signals on generation of effector and central memory CD4+ T cells.
    Soroosh P; Ine S; Sugamura K; Ishii N
    J Immunol; 2007 Oct; 179(8):5014-23. PubMed ID: 17911586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo.
    Schluns KS; Kieper WC; Jameson SC; Lefrançois L
    Nat Immunol; 2000 Nov; 1(5):426-32. PubMed ID: 11062503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
    Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 is positively involved in the development of colitogenic CD4+ IL-7R alpha high memory T cells in chronic colitis.
    Kameyama K; Nemoto Y; Kanai T; Shinohara T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Totsuka T; Hibi T; Watanabe M
    Eur J Immunol; 2010 Sep; 40(9):2423-36. PubMed ID: 20623548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro derivation of interferon-γ producing, IL-4 and IL-7 responsive memory-like CD4(+) T cells.
    Comber JD; Bamezai AK
    Vaccine; 2012 Mar; 30(12):2140-5. PubMed ID: 22281104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.
    Gramaglia I; Jember A; Pippig SD; Weinberg AD; Killeen N; Croft M
    J Immunol; 2000 Sep; 165(6):3043-50. PubMed ID: 10975814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation.
    Allard EL; Hardy MP; Leignadier J; Marquis M; Rooney J; Lehoux D; Labrecque N
    Eur J Immunol; 2007 Nov; 37(11):3069-77. PubMed ID: 17918202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
    Ishii N; Takahashi T; Soroosh P; Sugamura K
    Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigms.
    Scalzo-Inguanti K; Plebanski M
    Eur J Immunol; 2011 May; 41(5):1298-308. PubMed ID: 21469087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
    Takeda I; Ine S; Killeen N; Ndhlovu LC; Murata K; Satomi S; Sugamura K; Ishii N
    J Immunol; 2004 Mar; 172(6):3580-9. PubMed ID: 15004159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease.
    Moncrieffe H; Coles M; Stockinger B
    Immunology; 2008 Dec; 125(4):459-68. PubMed ID: 18498346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed death 1 regulates memory phenotype CD4 T cell accumulation, inhibits expansion of the effector memory phenotype subset and modulates production of effector cytokines.
    Charlton JJ; Tsoukatou D; Mamalaki C; Chatzidakis I
    PLoS One; 2015; 10(3):e0119200. PubMed ID: 25803808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.